Supplementary Figure 5: AM580 treatment prolongs CFU-C potential in hESC-derived cells. | Nature Cell Biology

Supplementary Figure 5: AM580 treatment prolongs CFU-C potential in hESC-derived cells.

From: Medial HOXA genes demarcate haematopoietic stem cell fate during human development

Supplementary Figure 5: AM580 treatment prolongs CFU-C potential in hESC-derived cells.

(A) Quantification of CFU-Cs generated from 10,000 EB- or FL-derived haematopoietic cells at day 24 ± 1 of OP9-M2 culture (mean ± s.e.m. from n = 4 independent experiments, statistics source data can be found in Supplementary Fig. 5B). (B) Table showing CFU counts for the indicated samples. Counts were rounded to the closest integer value (DM = DMSO, AM = AM580).

Back to article page